NCT02041468 2017-08-30Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC PatientsJewish General HospitalUnknown29 enrolled
NCT03240549 2017-08-07Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable DiseaseBeijing HospitalPhase 2 Unknown159 enrolled